Loading clinical trials...
Loading clinical trials...
The Torcetrapib project was terminated on December 2, 2006 due to safety findings. Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of cholesterol...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06451770 · Hypercholesterolemia, Hypertriglyceridemia, and more
NCT04634591 · Obesity, Diabetes Mellitus, and more
NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT06568601 · Hypercholesterolemia
NCT00353782 · Hypercholesterolemia, Atherosclerosis
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Mesa, Arizona
Pfizer Investigational Site
Alhambra, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions